| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/31/2023 | -3.33% | Morgan Stanley | $15 → $18 | Maintains | Equal-Weight |
| 01/23/2023 | 12.78% | Guggenheim | $17 → $21 | Maintains | Buy |
| 11/11/2022 | -19.44% | Morgan Stanley | $16 → $15 | Maintains | Equal-Weight |
| 11/10/2022 | -24.81% | RBC Capital | $18 → $14 | Maintains | Outperform |
| 11/10/2022 | -35.55% | Wells Fargo | $13 → $12 | Maintains | Underweight |
| 08/15/2022 | -8.7% | Mizuho | $18 → $17 | Maintains | Buy |
| 08/11/2022 | -14.07% | Morgan Stanley | $17 → $16 | Maintains | Equal-Weight |
| 08/11/2022 | -3.33% | RBC Capital | $16 → $18 | Maintains | Outperform |
| 08/11/2022 | -30.18% | Wells Fargo | $15 → $13 | Downgrades | Equal-Weight → Underweight |
| 05/12/2022 | -19.44% | Goldman Sachs | $17 → $15 | Maintains | Neutral |
| 03/14/2022 | -3.33% | Mizuho | $24 → $18 | Maintains | Buy |
| 03/11/2022 | -8.7% | Morgan Stanley | $21 → $17 | Maintains | Equal-Weight |
| 03/11/2022 | 7.41% | Deutsche Bank | $21 → $20 | Maintains | Buy |
| 03/11/2022 | -24.81% | BMO Capital | $20 → $14 | Maintains | Market Perform |
| 03/11/2022 | -14.07% | RBC Capital | $21 → $16 | Maintains | Outperform |
| 11/01/2021 | 12.78% | Guggenheim | → $21 | Initiates Coverage On | → Buy |
| 11/01/2021 | 12.78% | Deutsche Bank | → $21 | Initiates Coverage On | → Buy |
| 11/01/2021 | 34.26% | B of A Securities | → $25 | Initiates Coverage On | → Buy |
| 11/01/2021 | 2.04% | Wells Fargo | → $19 | Initiates Coverage On | → Equal-Weight |
| 11/01/2021 | 28.89% | Mizuho | → $24 | Initiates Coverage On | → Buy |
| 11/01/2021 | 12.78% | Morgan Stanley | → $21 | Initiates Coverage On | → Equal-Weight |
| 11/01/2021 | 12.78% | RBC Capital | → $21 | Initiates Coverage On | → Outperform |
| 11/01/2021 | 7.41% | BMO Capital | → $20 | Initiates Coverage On | → Market Perform |
| 11/01/2021 | 23.52% | Goldman Sachs | → $23 | Initiates Coverage On | → Neutral |
What is the target price for Life Time Group Hldgs (LTH)?
The latest price target for Life Time Group Hldgs (NYSE: LTH) was reported by Morgan Stanley on January 31, 2023. The analyst firm set a price target for $18.00 expecting LTH to fall to within 12 months (a possible -3.33% downside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Life Time Group Hldgs (LTH)?
The latest analyst rating for Life Time Group Hldgs (NYSE: LTH) was provided by Morgan Stanley, and Life Time Group Hldgs maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Life Time Group Hldgs (LTH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Life Time Group Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Life Time Group Hldgs was filed on January 31, 2023 so you should expect the next rating to be made available sometime around January 31, 2024.
Is the Analyst Rating Life Time Group Hldgs (LTH) correct?
While ratings are subjective and will change, the latest Life Time Group Hldgs (LTH) rating was a maintained with a price target of $15.00 to $18.00. The current price Life Time Group Hldgs (LTH) is trading at is $18.62, which is out of the analyst's predicted range.